Search

Filters
Clear All
  • 7
  • 42
  • 1
  • 531

Phase

  • 10
  • 11
  • 37
  • 6
  • 57
  • 5
  • 438
  • 528
  • 260

Found 581 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

N
Nabil Adra, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This is an open label randomized phase II trial of maintenance oral etoposide vs. observationwith relapsed GCT treated with high-dose chemotherapy (HDCT) and peripheral-blood(PBSCT).THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened …
M
Marissa Just
30 years or below
All genders
Phase 2
Interventional
What is the purpose of this study?This phase II trial studies how well combination chemotherapy works in treating patients withwly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens suchH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, …
N
Noah Parker, MD
22 years - 100 years
All genders
Interventional
What is this study about?The objective of this early feasibility study is to assess the safety of chronic dual site stimulation by adding infrahyoid stimulation in non-responding patients with pre-existing single-site hypoglossal nerve stimulation.This study will also assess whether the secondary Inspire System can achieve the intended purpose of causing …
T
Tina Zhang
2 years - 18 years
All genders
Interventional
What is this study about?The objective of this study is to assess the pharmacokinetics (PK), efficacy, and safety of risankizumab in pediatric subjects with moderately to severely active CD aged 2 to < 18 years old who have had intolerance or inadequate response to aminosalicylates, oral locally acting corticosteroids, systemic …
R
Raghu Motaganahalli, MD
20 years - 80 years
All genders
Interventional
What is this study about?The PERFORMANCE III study is a prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in subjects at elevated risk for carotid endarterectomy (CEA).Eligible patients greater than or equal to …
J
John Strobel, MD
18 years or above
All genders
Phase 3
Interventional
The purpose of this study is to evaluate if milvexian is at least as effective as apixabanducing the risk of the composite stroke and non- central nervous system (CNS) systemicbolism.
T
Tarah Ballinger, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?The purpose of this study is to study exercise in a novel population with indolent MBC (nogression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team hypothesizes that delivering virtual, supervised, progressive intensitybic and resistance training exercise for …
T
Toshihiro Onishi, MD
6 months - 21 years
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial compares hematopoietic (stem) cell transplantation (HCT) usinghed related donors (haploidentical [haplo]) versus matched unrelated donors (MUD) ing children, adolescents, and young adults with acute leukemia or myelodysplasticyndrome (MDS). HCT is considered standard of care treatment for patients with high-riskute leukemia …
M
Michael Ferguson, MD
All genders
Phase 3
Interventional
What is the purpose of this study?This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically …
R
Raj Vuppalanchi, MD
18 years - 75 years
All genders
Interventional
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnosticCT1 at discriminating those with NAS≥4 & F≥2 from those without.
31 - 40 of 581